Antidepressant use, depression, lifestyle factors, and new-onset diabetes

International Clinical Psychopharmacology

Volumn 26, Issue 3, 2011, Pages 159-168

  Wilkins, Tricia Lee ^a   Sambamoorthi, Usha ^a,b  

^a WEST VIRGINIA UNIVERSITY   (United States)

^b MOREHOUSE SCHOOL OF MEDICINE   (United States)

Author keywords

antidepressant drug; diabetes; incidence; new onset diabetes

Indexed keywords

ANTIDEPRESSANT AGENT;

ADULT; AGED; ARTICLE; CHI SQUARE TEST; CONFIDENCE INTERVAL; DEPRESSION; DIABETES MELLITUS; DISEASE COURSE; DISORDERS OF LIPID AND LIPOPROTEIN METABOLISM; DRUG USE; EXERCISE; FEMALE; HUMAN; HYPERTENSION; LIFESTYLE MODIFICATION; LOGISTIC REGRESSION ANALYSIS; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; OBESITY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RISK; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; ANTIDEPRESSIVE AGENTS; DEPRESSION; DEPRESSIVE DISORDER; DIABETES MELLITUS; FEMALE; HUMANS; HYPERTENSION; LIFE STYLE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; OBESITY; OVERWEIGHT; RISK FACTORS; TIME FACTORS; YOUNG ADULT;

EID: 79954572874     PISSN: 02681315     EISSN: 14735857     Source Type: Journal    
DOI: 10.1097/YIC.0b013e328342ce31     Document Type: Article

References (24)

1. American Diabetes Association. http://www.diabetes.org/diabetes-basics/ prevention/risk-factors/ [Accessed 1 May 2010].
2. Anderson RJ, Freedland KE, Clouse RE, Lustman PJ (2001). The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 24:1069-1078. (Pubitemid 33716379)
3. Andersohn F, Schade R, Suissa S, Garbe E (2009). Long-term use of antidepressants for depressive disorders and the risk of diabetes mellitus. Am J Psychiatry 166:591-598. [Epub 1 April 2010].
4. Atlantis E, Browning C, Sims J, Kendig H (2010). Diabetes incidence associated with depression and antidepressants in the Melbourne Longitudinal Studies on Healthy Ageing (MELSHA). Int J Geriatr Psychiatry 25:688-696. [Epub ahead of print].
5. Campayo A, De Jonge P, Roy JF, Saz P, De la Cámara C, Quintanilla MA, et al. (2010). Depressive disorder and incident diabetes mellitus: the effect of characteristics of depression. Am J Psychiatry 167:580-588. [Epub ahead of print].
6. De Groot M, Anderson R, Freedland KE, Clouse RE, Lustman PJ (2001). Association of depression and diabetes complications: a meta-analysis. Psychosom Med 63:619-630. (Pubitemid 32695143)
7. Diabetes Prevention Program (DPP) Research Group (2002). The Diabetes Prevention Program (DPP): description of lifestyle intervention. Diabetes Care 25:2165-2171.
8. Fournier JC, DeRubeis RJ, Hollon SD, Dimidjian S, Amsterdam JD, Shelton RC, Fawcett J (2010). Antidepressant drug effects and depression severity: a patient-level meta-analysis. JAMA 303:47-53.
9. Golden SH, Lazo M, Carnethon M, Bertoni AG, Schreiner PJ, Diez Roux AV, et al. (2008). Examining a bidirectional association between depressive symptoms and diabetes. JAMA 299:2751-2759. (Pubitemid 351846850)
10. Jorm AF, Mackinnon AJ, Henderson AS, Scott R, Christensen H, Korten AE, et al. (1995). The psychogeriatric assessment scales: a multidimensional alter- native to categorical diagnoses of dementia and depression in the elderly. Psychol Med 25:447-460.
11. Knol MJ, Geerlings MI, Egberts AC, Gorter KJ, Grobbee DE, Heerdink ER (2007). No increased incidence of diabetes in antidepressant users. Int Clin Psychopharmacol 22:382-386. (Pubitemid 47530844)
12. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM; Diabetes Prevention Program Research Group (2002). Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393-403. (Pubitemid 34437694)
13. Kriska AM, Saremi A, Hanson RL, Bennett PH, Kobes S, Williams DE, et al. (2003). Physical activity, obesity, and the incidence of type 2 diabetes in a high-risk population. Am J Epidemiol 158:669-675. (Pubitemid 37175515)
14. Lean ME, Pajonk FG (2003). Patients on atypical antipsychotic drugs: another high-risk group for type 2 diabetes. Diabetes Care 26:1597-1605. (Pubitemid 36929197)
15. Ley SH, Harris SB, Mamakeesick M, Noon T, Fiddler E, Gittelsohn J, et al. (2009). Metabolic syndrome and its components as predictors of incident type 2 diabetes mellitus in an Aboriginal community. CMAJ 180:617-624.
16. Linde JA, Simon GE, Ludman EJ, Ichikawa LE, Operskalski BH, Arterburn D, et al. (2010). A randomized controlled trial of behavioral weight loss treatment versus combined weight loss/depression treatment among women with comorbid obesity and depression. Ann Behav Med [Epub 28 September 2010].
17. Lustman PJ, Anderson RJ, Freedland KE, de Groot M, Carney RM, Clouse RE (2000). Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care 23:934-942. (Pubitemid 30480020)
18. Meisinger C, Löwel H, Thorand B, Döring A (2005). Leisure time physical activity and the risk of type 2 diabetes in men and women from the general population. The MONICA/KORA Augsburg Cohort Study. Diabetologia 48:27-34. [Epub 23 December 2004]. (Pubitemid 40174653)
19. Mezuk B, Eaton WW, Albrecht S, Golden SH (2008). Depression and type 2 diabetes over the lifespan: a meta-analysis. Diabetes Care 31:2383-2390.
20. Olfson M, Marcus SC (2009). National patterns in antidepressant medication treatment. Arch Gen Psychiatry 66:848-856.
21. Ollendorf DA, Joyce AT, Rucker M (2004). Rate of new-onset diabetes among patients treated with atypical or conventional antipsychotic medications for schizophrenia. Med Gen Med 6:5.
22. Rubin RR, Ma Y, Marrero DG, Peyrot M, Barrett-Connor EL, Kahn SE, et al.; Diabetes Prevention Program Research Group (2008). Elevated depression symptoms, antidepressant medicine use, and risk of developing diabetes during the diabetes prevention program. Diabetes Care 31:420-426. [Epub 10 December 2007].
23. Strano-Paul L, Phanumas D (2000). Diabetes management. Analysis of the American Diabetes Association's clinical practice recommendations. Geriatrics 55:57-62.
24. Yood MU, DeLorenze G, Quesenberry CP Jr, Oliveria SA, Tsai AL, Willey VJ, et al. (2009). The incidence of diabetes in atypical antipsychotic users differs according to agent-results from a multisite epidemiologic study. Pharma-coepidemiol Drug Saf 8:791-799.